A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Clinical trial NCT04074187 · COMPLETED

Trial details

NCT number: NCT04074187
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Thrombotic Thrombocytopenic Purpura

Start date: 2019-10-21
Primary completion: 2021-05-19
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.